Xplora Technologies AS
OSE:XPLRA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Dell Technologies Inc
NYSE:DELL
|
Technology
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Abercrombie & Fitch Co
NYSE:ANF
|
Retail
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
S&P Global Inc
NYSE:SPGI
|
Financial Services
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Citigroup Inc
NYSE:C
|
Banking
|
|
IE |
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Pharmaceuticals
|
|
US |
Medpace Holdings Inc
NASDAQ:MEDP
|
Life Sciences Tools & Services
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
11.65
29.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Dell Technologies Inc
NYSE:DELL
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Abercrombie & Fitch Co
NYSE:ANF
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
S&P Global Inc
NYSE:SPGI
|
US | |
Visa Inc
NYSE:V
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Citigroup Inc
NYSE:C
|
US | |
Iterum Therapeutics PLC
NASDAQ:ITRM
|
IE | |
Medpace Holdings Inc
NASDAQ:MEDP
|
US |
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Xplora Technologies AS
Revenue
|
1.2B
NOK
|
Cost of Revenue
|
-612.2m
NOK
|
Gross Profit
|
576.5m
NOK
|
Operating Expenses
|
-615.6m
NOK
|
Operating Income
|
-39.1m
NOK
|
Other Expenses
|
-12m
NOK
|
Net Income
|
-51.1m
NOK
|
Income Statement
Xplora Technologies AS
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||
Revenue |
200
N/A
|
187
-7%
|
256
+37%
|
364
+42%
|
431
+18%
|
451
+5%
|
469
+4%
|
499
+7%
|
502
+1%
|
524
+4%
|
604
+15%
|
656
+9%
|
689
+5%
|
1 189
+73%
|
|
Gross Profit | |||||||||||||||
Cost of Revenue |
(141)
|
(125)
|
(158)
|
(212)
|
(235)
|
(231)
|
(225)
|
(249)
|
(265)
|
(273)
|
(327)
|
(352)
|
(357)
|
(612)
|
|
Gross Profit |
60
N/A
|
62
+4%
|
99
+59%
|
152
+54%
|
196
+29%
|
220
+12%
|
243
+10%
|
250
+3%
|
237
-5%
|
251
+6%
|
277
+10%
|
304
+10%
|
332
+9%
|
577
+73%
|
|
Operating Income | |||||||||||||||
Operating Expenses |
(73)
|
(78)
|
(114)
|
(177)
|
(211)
|
(237)
|
(259)
|
(284)
|
(137)
|
(340)
|
(354)
|
(358)
|
(355)
|
(616)
|
|
Selling, General & Administrative |
(27)
|
(33)
|
(41)
|
(63)
|
(72)
|
(82)
|
(103)
|
(132)
|
(86)
|
(97)
|
(107)
|
(107)
|
(185)
|
(321)
|
|
Depreciation & Amortization |
(2)
|
(1)
|
(11)
|
(21)
|
(34)
|
(46)
|
(47)
|
(50)
|
(49)
|
(51)
|
(53)
|
(54)
|
(57)
|
(99)
|
|
Other Operating Expenses |
(43)
|
(43)
|
(61)
|
(93)
|
(104)
|
(109)
|
(109)
|
(102)
|
(2)
|
(191)
|
(195)
|
(197)
|
(113)
|
(196)
|
|
Operating Income |
(13)
N/A
|
(16)
-19%
|
(15)
+2%
|
(25)
-64%
|
(15)
+42%
|
(16)
-14%
|
(16)
+5%
|
(34)
-119%
|
100
N/A
|
(88)
N/A
|
(77)
+13%
|
(54)
+29%
|
(23)
+58%
|
(39)
-71%
|
|
Pre-Tax Income | |||||||||||||||
Interest Income Expense |
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
1
|
0
|
(1)
|
(185)
|
(3)
|
(5)
|
(2)
|
(2)
|
(11)
|
|
Total Other Income |
(8)
|
(7)
|
(6)
|
(7)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
1
|
(3)
|
(8)
|
(4)
|
(9)
|
|
Pre-Tax Income |
(25)
N/A
|
(26)
-4%
|
(23)
+8%
|
(33)
-40%
|
(17)
+49%
|
(17)
-3%
|
(16)
+7%
|
(36)
-129%
|
(85)
-135%
|
(89)
-4%
|
(83)
+7%
|
(63)
+23%
|
(30)
+53%
|
(59)
-100%
|
|
Net Income | |||||||||||||||
Tax Provision |
0
|
0
|
1
|
1
|
3
|
5
|
5
|
6
|
11
|
10
|
9
|
8
|
8
|
8
|
|
Income from Continuing Operations |
(25)
|
(26)
|
(22)
|
(32)
|
(14)
|
(12)
|
(11)
|
(30)
|
(74)
|
(79)
|
(74)
|
(56)
|
(21)
|
(51)
|
|
Net Income (Common) |
(25)
N/A
|
(26)
-4%
|
(22)
+12%
|
(32)
-41%
|
(14)
+57%
|
(12)
+11%
|
(11)
+10%
|
(30)
-180%
|
(74)
-147%
|
(79)
-6%
|
(74)
+6%
|
(56)
+25%
|
(21)
+62%
|
(51)
-139%
|
|
EPS (Diluted) |
-0.77
N/A
|
-0.67
+13%
|
-0.59
+12%
|
-0.79
-34%
|
-0.34
+57%
|
-0.31
+9%
|
-0.27
+13%
|
-0.74
-174%
|
-1.79
-142%
|
-1.88
-5%
|
-1.77
+6%
|
-1.33
+25%
|
-0.51
+62%
|
-1.19
-133%
|